Julie Kay Bush - Fishers IN Preston Charles Conrad - Indianapolis IN Merlyn Gerard Flom - Noblesville IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31445
US Classification:
514324, 546202
Abstract:
The present invention is directed to a novel crystalline hydrate of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]-phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride and uses for same, including inhibition of disease states associated with estrogen deprivation including cardiovascular disease, hyperlipidemia, and osteoporosis; and inhibition of other pathological conditions such as endometriosis, uterine fibrosis, estrogen-dependent cancer (including breast and uterine cancer), prostate cancer, benign prostatic hyperplasia, CNS disorders including Alzheimers disease, prevention of breast cancer, and up-regulating ChAT.
Crystalline Form Of 6-Hydroxy-3-(4-[2-(Piperidin-1-Yl)Ethoxy]Phenoxy)-2-(4-Methoxyphenyl)Benzo[B] Thiophene Hydrochloride
Julie Kay Bush - Fishers IN Preston Charles Conrad - Indianapolis IN Merlyn Gerard Flom - Noblesville IN Wayne Douglas Luke - West Lafayette IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
C07D40900
US Classification:
546202, 548525
Abstract:
The present invention is directed to a novel crystalline hydrate of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride and uses for same, including inhibition of disease states associated with estrogen deprivation including cardiovascular disease, hyperlipidemia, and osteoporosis; and inhibition of other pathological conditions such as endometriosis, uterine fibrosis, estrogen-dependent cancer (including breast and uterine cancer), prostate cancer, benign prostatic hyperplasia, CNS disorders including Alzheimers disease, prevention of breast cancer, and up-regulating ChAT.
Hemihydrate Of A Selective Functional M1 Muscarine Receptor Agonist
Julie Kay Bush - Fishers IN, US Perry Clark Heath - Indianapolis IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31/16 C07C 237/24
US Classification:
514613, 564161
Abstract:
The present invention provides crystalline biphenyl-4-carboxylic acid (R)-(6-(1-((4-fluorobenzyl)methylamino)ethylideneamino)-2(R)-hydroxyindan-1-yl)amide hemihydrate, compositions thereof, methods of using the same, processes for making the same, and processes for making intermediates thereof.
Salt And Crystalline Forms Of (2R)-Anti-5-{3-[4-(10,11-Difluoromethanodibenzosuber-5-Yl)Piperazin-1-Yl]-2-Hydroxypropoxy}Quinoline
Julie Kay Bush - Fishers IN, US Susan Marie Reutzel-Edens - Indianapolis IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31/50 C07D 487/00
US Classification:
544363, 51425306
Abstract:
The present invention provides novel salt and hydrate crystal forms of (2R)-anti-5-{3-[4-(10,11-difluoromethano-dibenzosuber-5-yl)piperazin-1-yl]-2-hydroxypropoxy}quinoline 2. 5 hydrochloride.
Salt And Crystalline Forms Of (2R)-Anti-5-{3-[4-(10,11-Difluoromethanodibenzosuber-5-Yl)Piperazin-1-Yl]-2-Hydroxypropoxy}Quinoline
Julie Kay Bush - Fishers IN, US Susan Marie Reutzel-Edens - Indianapolis IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31/50 C07D 487/00
US Classification:
544363, 51425306
Abstract:
The present invention provides methods of treating leukemia comprising administration of a resistance modulating amount of a compound having the formula (2r)-anti-5-{3-[4-(10,11-difluoromethano-dibenzosuber-5-yl)piperazin-1-yl]-2-hydroxypropoxy}quinoline 2. 5 hydrochloride.
Crystalline Variable Hydrate Of (S)-6-(4-(2-((3-9H-Carbazol-4-Yloxy)-2-Hydroxypropyl)Amino)-2-Methylpropyl)Phenoxy)-3-Pyridinecarbox Amide Hemisuccinate Salt
The present invention relates to a crystalline variable hydrate of (S)-(3-pyridinecarboxamide,6-[4-[2-[[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl]amino]-2-methylpropyl]phenoxy]) -hemi-succinate, a pharmaceutical formulation containing said salt and to methods for treating obesity and/or Type 2 diabetes using said salt.
The present invention relates olanzapine pamoate dihydrate, pharmaceutical compositions thereof and use in treating certain mental disorders, such as schizophrenia.
Julie Kay Bush - Fishers IN, US Margaret Mary Faul - Zionsville IN, US Susan Marie Reutzel-Edens - Zionsville IN, US
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 31/41 A61K 31/40 C07D 209/02 C07D 209/00
US Classification:
514414, 548455, 548466, 548468
Abstract:
The present invention relates to crystalline 2,5-dione-3-(1-methyl-1H-indol-3-yl)-4-[1-(pyridin-2-yl-methyl)piperidin-4-yl]-1H-indol-3-yl]-1H-pyrrole mono-hydrochloride salt, a pharmaceutical formulation containing said salt and to methods for treating cancer and for inhibiting tumor growth using said salt.
Tails Pet Media Group since Jan 2010
Regional Publisher
MediaSauce Jun 2009 - Nov 2009
Business Development
Vibrant Nation Jul 2008 - Mar 2009
Business Development Manager
DBS>Interactive Jan 2008 - Jul 2008
Director of New Business Development
Angie's List Dec 2005 - Jan 2008
National Product Advertising Director
Education:
The Art Institutes 1994 - 1996
Associates, Management
Art Institute of Ft. Lauderdale 1982 - 1984
Associates, Photography, Graphic Design
Ball State University 1979 - 1980
John Marshall High School 1979
The Art Institutes
Skills:
Email Marketing Social Media Marketing Digital Marketing Advertising Marketing Online Advertising Social Media Social Networking Leadership Public Relations Sales Marketing Strategy Digital Strategy Seo Management B2B Account Management Business Development New Business Development Online Marketing E Commerce Digital Media Marketing Communications Sem Sales Management Fundraising Product Marketing Creative Direction Mobile Marketing Facebook New Media Interactive Marketing Direct Marketing Sales Process Strategic Partnerships Lead Generation Content Strategy Media Planning Blogging Publishing Integrated Marketing Google Analytics Ppc Content Management Strategic Thinking Copywriting Multi Channel Marketing Affiliate Marketing Advertising Sales Licensing
Interests:
Economic Empowerment Civil Rights and Social Action Poverty Alleviation Human Rights Animal Welfare Arts and Culture
Languages:
Spanish English
Certifications:
Casualty Claim Adjuster State of Connecticut Insurance Department
Eli Lilly and Company
Cm and C Project Management
Eli Lilly and Company Feb 2012 - Apr 2014
Project Manager - Clinical Trial Material Manufacturing and Services
Eli Lilly and Company Dec 2010 - Feb 2012
Consultant - Chemistry, Manufacturing and Controls, Chorus
Eli Lilly and Company Feb 2007 - Dec 2010
Six Sigma Black Belt - Product Research and Development
Eli Lilly and Company Jan 1996 - Feb 2007
Associate Senior Analytical Chemist
Education:
University of Illinois at Urbana - Champaign 1993 - 1996
Master of Science, Masters, Chemistry
Illinois State University 1989 - 1993
Bachelors, Bachelor of Science, Chemistry
Stanford Law School Degree - J.D. Graduated - 1999 University of Michigan Degree - M.A. Graduated - 1995 Princeton University Degree - A.B. Graduated - 1995